InvestSMART

Noxopharm Limited (ASX: NOX) - Announcements

- Current share price for NOX : $0.036

ASX company news and announcements for Noxopharm Limited (NOX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Noxopharm Limited (NOX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Noxopharm Limited (NOX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Noxopharm Limited (NOX)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$12 Notice of Extraordinary General Meeting/Proxy Form 17 Nov 2026 3:10PM $0.037 $0.036 fallen by 2.70%
$12 Results of Meeting 17 Nov 2026 2:56PM $0.037 $0.036 fallen by 2.70%
$12 Noxopharm 2026 AGM Corporate Presentation 17 Nov 2026 8:28AM $0.037 $0.036 fallen by 2.70%
$12 Noxopharm 2026 AGM Chair's Address 17 Nov 2026 8:28AM $0.037 $0.036 fallen by 2.70%
$12 Noxopharm receives $1.4 million R&D tax incentive rebate 12 Nov 2026 1:44PM $0.035 $0.036 risen by 2.86%
$12 Noxopharm Investor Webinar 6 Nov 2026 8:24AM $0.035 $0.036 risen by 2.86%
$12 Cleansing Statement 5 Nov 2026 10:19AM $0.035 $0.036 risen by 2.86%
$12 Application for quotation of securities - NOX 5 Nov 2026 10:04AM $0.035 $0.036 risen by 2.86%
$12 Proposed issue of securities - NOX 3 Nov 2026 8:40AM $0.048 $0.036 fallen by 25%
$12 Proposed issue of securities - NOX 2 Nov 2026 2:34PM $0.048 $0.036 fallen by 25%
$12 Quarterly Activities/Appendix 4C Cash Flow Report 2 Nov 2026 10:53AM $0.049 $0.036 fallen by 26.53%
$12 Proposed issue of securities - NOX 2 Nov 2026 10:53AM $0.049 $0.036 fallen by 26.53%
$12 Proposed issue of securities - NOX 2 Nov 2026 10:53AM $0.049 $0.036 fallen by 26.53%
$12 Reinstatement to Quotation 2 Nov 2026 10:53AM $0.049 $0.036 fallen by 26.53%
$12 Noxopharm Successfully Raises $1.5 Million via Placement 2 Nov 2026 10:53AM $0.049 $0.036 fallen by 26.53%
$12 Voluntary Suspension 29 Oct 2026 8:58AM $0.049 $0.036 fallen by 26.53%
$12 Trading Halt 27 Oct 2026 8:57AM $0.049 $0.036 fallen by 26.53%
$12 2026 AGM Letter of Access, Notice of Meeting and Proxy 16 Oct 2026 11:50AM $0.050 $0.036 fallen by 28%
$12 Appendix 4G and Corporate Governance Statement 16 Oct 2026 10:45AM $0.050 $0.036 fallen by 28%
$12 Annual Report to shareholders 16 Oct 2026 10:32AM $0.050 $0.036 fallen by 28%
$12 FDA feedback supports SOF-SKN Phase II plans 8 Oct 2026 8:15AM $0.062 $0.036 fallen by 41.94%
$12 Audited Financial Statements 30 Sep 2026 4:05PM $0.059 $0.036 fallen by 38.98%
$12 SOF-SKN to progress to extension study in CLE patients 14 Sep 2026 8:23AM $0.072 $0.036 fallen by 50%
$12 Investor Presentation September 2026 4 Sep 2026 8:11AM $0.080 $0.036 fallen by 55%
$12 Novel oligonucleotides data presented at Options Conference 1 Sep 2026 9:36AM $0.089 $0.036 fallen by 59.55%

1 - 25 of 821 results

Page 1 of 33

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.